SC 13G/A 1 oxfd-sc13ga_021021.htm AMENDMENT TO FORM SC 13G

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G/A

Under the Securities Exchange Act of 1934*

Oxford Immunotec Global PLC

(Name of Issuer)

 

Common Stock, $0.01 par value

(Title of Class of Securities)

 

G6855A103

(CUSIP Number)

 

February 10, 2021
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

  Rule 13d-1(b)
     
  Rule 13d-1(c)
     
  Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

CUSIP No . G6855A103   Page 2 of 7

 

1

NAME OF REPORTING PERSONS
First Light Asset Management, LLC

 

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
(ENTITIES ONLY)

46-3521994

 
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☐

(b) ☐

3 SEC USE ONLY  
4

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

 

NUMBER OF
SHARES

BENEFICIALLY
OWNED BY

EACH
REPORTING

PERSON
WITH:

5

SOLE VOTING POWER

0

 
6

SHARED VOTING POWER

0

 
7

SOLE DISPOSITIVE POWER

0

 
8

SHARED DISPOSITIVE POWER

0

 
9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

0

 
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

0.0%

 
12

TYPE OF REPORTING PERSON

IA

 
         

 

 

 

 

CUSIP No . G6855A103   Page 3 of 7

 

1

NAME OF REPORTING PERSONS
Mathew P. Arens

 

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
(ENTITIES ONLY)

 
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☐

(b) ☐

3 SEC USE ONLY  
4

CITIZENSHIP OR PLACE OF ORGANIZATION

United State of America

 

NUMBER OF
SHARES

BENEFICIALLY
OWNED BY

EACH
REPORTING

PERSON
WITH:

5

SOLE VOTING POWER

60,078

 
6

SHARED VOTING POWER

35,322

 
7

SOLE DISPOSITIVE POWER

60,078

 
8

SHARED DISPOSITIVE POWER

35,322

 
9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

95,400

 
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

0.37%

 
12

TYPE OF REPORTING PERSON

IN

 

 

 

 

 

CUSIP No. G6855A103   Page 4 of 7

 

Item 1(a).   Name of Issuer:
    Oxford Immunotec Global PLC
     
Item 1(b).   Address of Issuer’s Principal Executive Offices:
    94C Innovation Drive, Milton Park, Abingdon OX14 4RZ, United Kingdom
     
Item 2(a).   Name of Person Filing:
   

This Schedule 13G/A is being jointly filed by the following:

 

First Light Asset Management, LLC (the “Manager”)

Mathew P. Arens (“Mr. Arens”)

   

 

The Manager is deemed to be the beneficial owner of 0 of the Issuer’s shares (the “Shares”). The Manager acts as an investment adviser to certain persons holding separately managed accounts with the Manager, each of whom has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, those shares. The Manager may also be deemed to be the beneficial owner of these shares because it acts as an investment adviser to certain private funds. Mr. Arens is also deemed to be the beneficial owner of these shares because he controls the Manager in his position as managing member and majority owner of the Manager. Mr. Arens also directly holds 60,078 Shares in an individual capacity with sole control and 35,322 shares held in a joint account over which he shares control. The Manager and Mr. Arens are filing this Schedule 13G/A with respect to these Shares pursuant to Rule 13d-1(b) under the Act.

 

The Manager and Mr. Arens may be deemed to be the beneficial owner of the total amount of Shares set forth across from its or his respective name in Item 4 below. The filing of this Schedule 13G shall not be construed as an admission that the reporting persons or any of their affiliates are the beneficial owner of any securities covered by this Schedule 13G for any other purposes other than Section 13(d) of the Securities Exchange Act of 1934.

     
Item 2(b).   Address of Principal Business Office or, if None, Residence:
   

Each of the reporting persons identified in Item 2(a) has its principal business office at:

 

3300 Edinborough Way, Suite 201, Edina, MN 55435

     
Item 2(c).   Citizenship:
   

First Light Asset Management, LLC – Delaware limited liability company

Mathew P. Arens – United States citizen

     
Item 2(d).   Title of Class of Securities:
    Common Stock, $0.01 par value
     
Item 2(e).   CUSIP Number:
    G6855A103
     
Item 3. If This Statement is Filed Pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), Check Whether the Person Filing is a:
  (a) Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
       
  (b) Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
       
  (c) Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
       
  (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
       
  (e) An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

 

 

 

CUSIP No. G6855A103   Page 5 of 7

 

 

  (f) An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
       
  (g) A parent holding company or control person in accordance with §240.13d-1(b)(ii)(G);
       
  (h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
       
  (i) A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
       
  (j) Group, in accordance with §240.13d-1(b)(1)(ii)(J).
       
Item 4. Ownership.
   
  Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
   
  (a) Amount beneficially owned:
   

First Light Asset Management, LLC – 0

Mathew P. Arens – 95,400

     
  (b) Percent of class:
   

First Light Asset Management, LLC – 0.0%

Mathew P. Arens – 0.37%

 
     
  (c) Number of shares as to which such person has:
     
    (i) Sole power to vote or to direct the vote
     

First Light Asset Management, LLC – 0

Mathew P. Arens – 60,078

       
    (ii) Shared power to vote or to direct the vote
     

First Light Asset Management, LLC – 0

Mathew P. Arens – 35,322

       
    (iii) Sole power to dispose or to direct the disposition of
     

First Light Asset Management, LLC – 0

Mathew P. Arens – 60,078

       
    (iv) Shared power to dispose or to direct the disposition of
     

First Light Asset Management, LLC – 0

Mathew P. Arens – 35,322

 

 

 

 

CUSIP No . G6855A103   Page 6 of 7

 

Item 5. Ownership of Five Percent or Less of a Class.
  If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☒
   
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
  Not applicable
   
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
  Not applicable
   
Item 8. Identification and Classification of Members of the Group.
  Not applicable
   
Item 9. Notice of Dissolution of Group.
  Not applicable
   
Item 10. Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

   
 

FIRST LIGHT ASSET MANAGEMENT, LLC

 

Date: February 10, 2021

     
  By: /s/ Kurt T. Peterson
  Name: Kurt T. Peterson
  Title: Chief Compliance Officer
     
 

 

Date: February 10, 2021

 
  Signature: /s/ Mathew P. Arens
  Name: Mathew P. Arens
   

 

 

 

 


CUSIP No .
G6855A103   Page 7 of 7

 

Exhibit A

JOINT FILING AGREEMENT

 

 

The Undersigned agree that the statement on Schedule 13G/A with respect to the common stock of Oxford Immunotec Global PLC, dated as of February 10, 2021, is, and any amendment thereto signed by each of the undersigned shall be, filed on behalf of each of them pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.

 

 

 

  FIRST LIGHT ASSET MANAGEMENT, LLC

 

 By:/s/ Kurt T. Peterson  
Name:Kurt T. Peterson
Title:Chief Compliance Officer

 

 By:/s/ Mathew P. Arens  
Name:Mathew P. Arens